To include your compound in the COVID-19 Resource Center, submit it here.

ChAd3-EBO-Z: Phase I started

Oxford University began a U.K. Phase I trial to evaluate intramuscular

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE